TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,000 | -33.3% | 3,000 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q1 2022 | $3,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q4 2021 | $3,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q3 2021 | $3,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q4 2020 | $3,000 | -76.9% | 3,000 | -76.9% | 0.00% | – |
Q3 2020 | $13,000 | 0.0% | 13,000 | 0.0% | 0.00% | – |
Q2 2020 | $13,000 | +333.3% | 13,000 | +333.3% | 0.00% | – |
Q1 2020 | $3,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | -98.1% | 3,000 | -98.2% | 0.00% | – |
Q2 2019 | $154,000 | +5033.3% | 168,000 | +5500.0% | 0.00% | – |
Q1 2019 | $3,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -25.0% | 3,000 | -25.0% | 0.00% | – |
Q3 2018 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | -87.9% | 4,000 | -89.5% | 0.00% | – |
Q1 2018 | $33,000 | +725.0% | 38,000 | +850.0% | 0.00% | – |
Q4 2017 | $4,000 | -99.8% | 4,000 | -99.8% | 0.00% | – |
Q3 2017 | $1,985,000 | -43.1% | 2,202,000 | -32.3% | 0.00% | -100.0% |
Q2 2017 | $3,488,000 | +1.1% | 3,252,000 | +1.2% | 0.00% | 0.0% |
Q1 2017 | $3,450,000 | -18.6% | 3,213,000 | -17.0% | 0.00% | 0.0% |
Q4 2016 | $4,239,000 | -2.9% | 3,871,000 | +5.9% | 0.00% | 0.0% |
Q3 2016 | $4,364,000 | +18.2% | 3,657,000 | +25.3% | 0.00% | 0.0% |
Q2 2016 | $3,691,000 | +54.8% | 2,918,000 | +59.2% | 0.00% | 0.0% |
Q1 2016 | $2,385,000 | -54.5% | 1,832,500 | -45.5% | 0.00% | 0.0% |
Q4 2015 | $5,247,000 | -15.7% | 3,360,500 | -27.0% | 0.00% | -50.0% |
Q3 2015 | $6,225,000 | +28195.5% | 4,604,500 | +28678.1% | 0.00% | – |
Q2 2015 | $22,000 | +120.0% | 16,000 | +128.6% | 0.00% | – |
Q1 2015 | $10,000 | +11.1% | 7,000 | 0.0% | 0.00% | – |
Q4 2014 | $9,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
Q3 2014 | $9,000 | -82.4% | 7,000 | -82.5% | 0.00% | – |
Q2 2014 | $51,000 | +466.7% | 40,000 | +471.4% | 0.00% | – |
Q1 2014 | $9,000 | +80.0% | 7,000 | +40.0% | 0.00% | – |
Q4 2013 | $5,000 | -77.3% | 5,000 | -76.2% | 0.00% | – |
Q3 2013 | $22,000 | +2100.0% | 21,000 | +2000.0% | 0.00% | – |
Q2 2013 | $1,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Radcliffe Capital Management, L.P. | 70,783,000 | $69,363,000 | 6.27% |
INCOME RESEARCH & MANAGEMENT | 14,978,000 | $14,536,000 | 5.17% |
PIPER SANDLER & CO. | 5,000,000 | $4,852,000 | 3.63% |
Western Asset Management Company, LLC | 42,946,000 | $42,102,000 | 3.46% |
PenderFund Capital Management Ltd. | 4,000,000 | $5,225,000 | 1.45% |
Bracebridge Capital, LLC | 5,500,000 | $5,335,000 | 0.85% |
WESTWOOD HOLDINGS GROUP INC | 43,185,000 | $42,490,000 | 0.54% |
CORBYN INVESTMENT MANAGEMENT INC/MD | 1,025,000 | $995,000 | 0.52% |
LMR Partners LLP | 22,235,000 | $21,742,000 | 0.45% |
JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,357,000 | 0.36% |